Outlaw Feed, LLC – Trademark Portfolio

Entity Type: 16

Outlaw Feed, LLC holds 3 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 2 filings in this category. The portfolio also extends into Class 35 (Advertising & Business) across 2 Nice Classification classes. Currently, 3 trademarks are registered. Notable registered marks include STOCKED UP, OUTLAW FEED, and OUTLAW NUTRITION. The owner is based in Inver Grove Heights, MN.

4046 69th Street E

Inver Grove Heights, MN 55076

3 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Trademark Classifications

Outlaw Feed, LLC's trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

5
Pharmaceuticals (2 filings)

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

35
Advertising & Business (1 filing)

Advertising; business management; business administration; office functions

Frequently Asked Questions

How many trademarks does Outlaw Feed, LLC have?

Outlaw Feed, LLC has 3 U.S. trademarks filed with the USPTO. Of these, 3 registered.

What trademark classes does Outlaw Feed, LLC file in?

Outlaw Feed, LLC files trademarks across 2 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 35 (Advertising & Business). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.

What are Outlaw Feed, LLC's most well-known trademarks?

Outlaw Feed, LLC's registered trademark portfolio includes well-known marks such as STOCKED UP, OUTLAW FEED, and OUTLAW NUTRITION. These are among 3 currently registered trademarks in the portfolio.

What is Outlaw Feed, LLC's trademark registration success rate?

Outlaw Feed, LLC has a 100% trademark registration rate, with 3 out of 3 resolved applications resulting in successful registration. Currently, 0 applications are pending review.